How Dr. Daniel Brennan uses diverse approaches to dd-cfDNA surveillance - immunosuppression modulation and tracking total dd-cfDNA over time
In this episode of our Inside the ProActive Study Podcast, Dr. Daniel Brennan gives us his thoughts on: • Why “50% of DSA’s are clinically meaningless” when monitoring for rejection. • His dd-cfDN
Listen Now